Renalytix and Carna Health Partner on AI Kidney Disease Management

May 12, 2026
Renalytix and Carna Health have announced a partnership integrating the kidneyintelX.dkd diagnostic test with Carna Health’s AI platform to improve early detection and management of chronic kidney disease.

Renalytix and Carna Health have announced a partnership to improve how health systems identify and manage chronic kidney disease, according to a press release.

The collaboration integrates Renalytix’s FDA approved kidneyintelX.dkd test, which predicts the risk of kidney function decline in patients with type 2 diabetes and early stage chronic kidney disease, with Carna Health’s AI driven digital prevention and care management platform.

The combined approach is designed to help health systems move from traditional detection to risk guided, personalized care pathways. This integration aims to support earlier interventions for patients at risk of kidney failure and reduce the frequency of emergency dialysis starts.

The companies stated that the partnership could help address the high costs associated with chronic kidney disease, which currently exceeds 130 billion dollars in annual Medicare spending.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

05/12
Coupa Acquires Rossum to Expand AI Document Processing Across Spend Management Platform
05/12
Saturn Cloud and Mirantis Partner on Full Stack AI Platform for NeoClouds and Enterprises
05/12
CGI Expands IT Partnership with Stockmann to Advance Digital Development
05/12
AccountTECH Invests in Private AI Infrastructure for Accounting Applications
05/12
Bounteous Acquires Cartesian to Strengthen Data and AI Capabilities

More from: Life Sciences

05/12
IPC Global Named Technology Partner for American Medical Association Precision Education Grant
05/12
Labcorp Expands Diagnostic Integration with Epic's Aura Platform
05/12
Hyro Report Shows Deep EHR Integrations Drive Higher ROI for Healthcare AI Agents
05/12
Susan Wojcicki Foundation Launches to Advance Early Detection of Lung Cancer
05/12
Ribo and Insilico Medicine Partner to Advance AI Guided siRNA Drug Development

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You May Also Like